News Details

(As on May 02, 2025, 15:59)

Back

Sudarshan Pharma Ind - Announcement under Regulation 30 (LODR)-Change in Directorate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that w.e.f. 01-May-2025, \r\n(i) Mr. Sachin Mehta is resigned as the Chief Financial Officer of the Company, he shall continue as the Joint Managing Director of the Company and \r\n(ii) Mr. Manoj Lodha has been appointed as the Chief Financial Officer of the Company.

ATTENTION INVESTORS

"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)

Designed, developed and content provided by

News

News Details

SMS Registration

Mobile Trading

Investors Grievances

Invest By QFI

CLIENT LOGIN

FRANCHISEE LOGIN

INTERNET TRADING